Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

pharma nord aps, tinglykke 4-6, dk-6500, vojens - kapsula

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

pharma nord aps - kapsula

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

otsuka novel products gmbh - delamanīds - tuberkuloze, pret multidrugiem izturīga - antimikobaktērijas - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 un 5. jāņem vērā oficiālās vadlīnijas par piemērotu izmantot antibakteriālas vielas.

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

pharma nord aps - kapsula

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - imūnsupresanti - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - cistiskā fibroze - other respiratory system products - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

amarin pharmaceuticals ireland limited - icosapent ethyl - dislipidēmijas - lipīdu modificējoši aģenti - indicated to reduce cardiovascular risk as an adjunct to statin therapy.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianēmiski līdzekļi - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cistiskā fibroze - other respiratory system products - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

pharma nord aps - kapsula